I’m happy to hear about this new development in the diagnosis of Alzheimer’s disease: The FDA has approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, the first-ever blood test to aid in diagnosing Alzheimer’s. Until now, confirming amyloid...
